Figure 2.

Sodium fluoride computed tomography/positron emission tomography (CT/PET) scans in a patient with bone metastases. (A) Sodium fluoride CT/PET scan showing diffuse metastatic bone disease before treatment with regression and many lesions 10 months after treatment with sipuleucel-T followed by enzalutamide. (B) CT scan of the pelvis showing pelvic lymph node enlargement (red arrows) before treatment with sipuleucel-T followed by enzalutamide with regression of nodes 10 months after treatment.